These data reflected that Oxysophocarpine decreased FGL1 expression through downregulating IL‐6‐mediated JAK2/STAT3 signal pathway in HCC cells and subsequently sensitize anti‐Lag3 therapeutic effect. The gene discussed is FGL1; the disease is hepatocellular carcinoma.